#USA #Las Vegas #regenerative medicine #Kelyniam Global #cranial implants

Kelyniam Global to Present at Planet MicroCap Las Vegas 2026

Kelyniam Global, Inc. (OTC: KLYG), renowned for its advanced cranial and craniofacial implants, is set to make a significant mark in the medical industry as it presents at the upcoming Planet MicroCap Las Vegas 2026. Scheduled for Wednesday, June 17, 2026, at the prestigious Bellagio Resort Hotel, the presentation will commence at 4:30 PM PST, outlining the company’s journey and innovations in the domain of regenerative medicine.

A New Era for Kelyniam Global

This conference marks Kelyniam's debut in the event series, a moment CEO Ross Bjella expresses enthusiasm about. “We’ve proudly evolved from a single-product PEEK company into a clear leader in regenerative neurosurgery,” Bjella stated. He emphasizes the company’s commitment to improving surgical outcomes through a growing suite of advanced biomaterials that promote effective bone integration.

What to Expect at the Conference

The presentation will encompass the following key highlights:

1. Fusion™ Implant Launch: This FDA-cleared BCP-PEEK implant represents the first new material to gain approval in the U.S. cranial market in eight years. With a great balance of strength and superior bone integration, the initial implant was successfully delivered in April, demonstrating exceptional integration capabilities within 24-48 hours.

2. Regenerative Leadership: Kelyniam stands out as the only company providing a comprehensive product portfolio, including the Fusion™ BCP-PEEK implants, CustomizedBone™ hydroxyapatite, designed for pediatric applications, and Osteopore polycaprolactone products.

3. Financial Momentum: The company’s financials show significant growth, with Q1 2026 revenues hitting $1.15 million, reflecting an impressive 84% YoY increase. Gross profit soared by 105%, resulting in an operating income of $295,295. These statistics indicate strong market positioning and operational efficiency.

4. Strategic Acceleration: Kelyniam has expanded its licensing agreements and developed new partnerships while attracting veteran Kris Renton as the Chief Revenue Officer, further solidifying its growth trajectory in the medical sector.

The Road Ahead

The presentation is set to highlight Kelyniam’s distinct regenerative platform, showcasing their rapid manufacturing capabilities, and establishing a clear path toward sustained growth within the cranial reconstruction market. As Kelyniam continues to redefine the boundaries of cranial implant technology, the Planet MicroCap Las Vegas 2026 will serve as a vital platform for sharing its innovations.

About Kelyniam Global, Inc.

Kelyniam Global, Inc. specializes in the rapid production of tailored cranial and craniofacial implants through advanced CAD/CAM technology and next-level biomaterials. With a focus on turnaround times as quick as 24-48 hours, the company collaborates closely with neurosurgeons to achieve superior clinical outcomes and economic value.

For more details, please visit Kelyniam Global's official website.

Cautionary Statement: This article contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Actual results may differ due to various risks and uncertainties. For more insights, Kelyniam’s SEC filings contain comprehensive details.